Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohnʼs Disease, and Pouchitis: Meta-analysis of Randomized Controlled Trials

Assessing the quality of reports of randomized clinical trials: Is blinding necessary?

Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582 · see citing works

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial

Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., & Campieri, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.9370 · Cited by 1,485 · see citing works

Maintaining remission of ulcerative colitis with the probiotic <i>Escherichia coli</i> Nissle 1917 is as effective as with standard mesalazine

Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · see citing works

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K. M., Brigidi, P., Vitali, B., Poggioli, G., Miglioli, M., & Campieri, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00171-9 · Cited by 1,147 · see citing works

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

Rembacken, B., Snelling, A. M., Hawkey, P. M., Chalmers, D. M., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,100 · see citing works

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,053 · see citing works

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

Mimura, T., Rizzello, F., Helwig, U., Poggioli, G., Schreiber, S., Talbot, I. C., Nicholls, R. J., Gionchetti, P., Campieri, M., & Kamm, M. A. (2003) · Gut · doi:10.1136/gut.53.1.108 · Cited by 912 · see citing works

Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

Kruis, W., SCHÜTZ, E., Fric, P., Fixa, B., Judmaier, G., & Stolte, M. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00225.x · Cited by 774 · see citing works

Synbiotic therapy ( <i>Bifidobacterium longum</i> /Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766 · see citing works

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG

Prantera, C. (2002) · Gut · doi:10.1136/gut.51.3.405 · Cited by 566 · see citing works

Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis

Miele, E., Pascarella, F., Giannetti, E., Quaglietta, L., Baldassano, R. N., & Staiano, A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.118 · Cited by 517 · see citing works

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis

Sood, A., Midha, V., Makharia, G. K., Ahuja, V., Singal, D., Goswami, P., & Tandon, R. K. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.016 · Cited by 513 · see citing works

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.218 · Cited by 489 · cited 3× · see citing works

Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis

Mennigen, R. B., Nolte, K., Rijcken, E. J. M., Utech, M., Loeffler, B., Senninger, N. J., & Bruewer, M. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90534.2008 · Cited by 484 · see citing works

Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis

Zocco, M. A., Verme, L. Z. D., Cremonini, F., Piscaglia, A. C., Nista, E. C., Candelli, M., Novi, M., Rigante, D., Cazzato, I. A., Ojetti, V., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02927.x · Cited by 472 · see citing works

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

Marteau, P. R., Lémann, M., Seksik, P., Laharie, D., Colombel, J. F., Bouhnik, Y., Cadiot, G., Soulé, J. C., Bourreille, A., Metman, E.-H., et al. (2005) · Gut · doi:10.1136/gut.2005.076604 · Cited by 412 · see citing works

Crohn's Disease and Escherichia coli

Malchow, H. A. (1997) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199712000-00021 · Cited by 402 · see citing works

Randomized placebo‐controlled trial assessing the effect of bifidobacteria‐fermented milk on active ulcerative colitis

Kato, K., Mizuno, S., Umesaki, Y., Ishii, Y., Sugitani, M., Imaoka, A., Otsuka, M., Hasunuma, O., Kurihara, R., Iwasaki, A., et al. (2004) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/j.1365-2036.2004.02268.x · Cited by 397 · see citing works

Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide

Fernandez, E. M., Valenti, V., Rockel, C., Hermann, C., Pot, B., Boneca, I. G., & Grangette, C. (2011) · Gut · doi:10.1136/gut.2010.232918 · Cited by 376 · see citing works

A Randomized, Double-blind Trial of Lactobacillus GG Versus Placebo in Addition to Standard Maintenance Therapy for Children with Crohnʼs Disease

Bousvaros, A., Guandalini, S., Baldassano, R. N., Botelho, C. A., Evans, J., Ferry, G. D., Goldin, B. R., Parker‐Hartigan, L., Kugathasan, S., Levy, J. F., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000175905.00212.2c · Cited by 363 · see citing works

Lactobacillus GG in inducing and maintaining remission of Crohn's disease

Schultz, M., Timmer, A., Herfarth, H. H., Sartor, R. B., Vanderhoof, J. A., & Rath, H. C. (2004) · BMC Gastroenterology · doi:10.1186/1471-230x-4-5 · Cited by 349 · see citing works

Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?

Rutgeerts, P., Vermeire, S. A. R. A., & Assche, G. V. (2007) · Gut · doi:10.1136/gut.2005.088732 · Cited by 325 · see citing works

Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohnʼs disease after ileo-caecal resection

Gossum, A. V., Dewit, O., Louis, E. J., Hertogh, G., Baert, F., Fontaine, F., Devos, M., Enslen, M., Paintin, M., & Franchimont, D. P. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20063 · Cited by 296 · see citing works

Pouchitis: result of microbial imbalance?

Embden, J. G. R.-V., Schouten, W. R., & van Lieshout, L. M. (1994) · Gut · doi:10.1136/gut.35.5.658 · Cited by 255 · see citing works

Clinical trial: the microbiological and immunological effects of synbiotic consumption – a randomized double‐blind placebo‐controlled study in active Crohn’s disease

Steed, H., Macfarlane, G. T., Blackett, K. L., Bahrami, B., Reynolds, N., Walsh, S., Cummings, J. H., & Macfarlane, S. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04417.x · Cited by 247 · see citing works

Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.

Tursi, A., Brandimarte, G., Giorgetti, G. M., Forti, G., Modeo, M. E., & Gigliobianco, A. (2004) · PubMed · Cited by 241 · see citing works

Probiotics in the Management of Inflammatory Bowel Disease: A Systematic Review of Intervention Studies in Adult Patients

Jonkers, D., Penders, J., Masclee, A., & Pierik, M. (2012) · Drugs · doi:10.2165/11632710-000000000-00000 · Cited by 240 · see citing works

Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment

Ulisse, S., Gionchetti, P., D’Alò, S., Russo, F. P., Pesce, I., Ricci, G., Rizzello, F., Helwig, U., Cifone, M. G., Campieri, M., et al. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04139.x · Cited by 214 · see citing works

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

Matthes, H., Krummenerl, T., Giensch, M., Wolff, C., & Schulze, J. (2010) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-10-13 · Cited by 207 · see citing works

Probiotics for induction of remission in Crohn's disease

Limketkai, B. N., Akobeng, A. K., Gordon, M. A., & Adepoju, A. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006634.pub3 · Cited by 205 · see citing works

Probiotics for maintenance of remission in ulcerative colitis

Iheozor‐Ejiofor, Z., Kaur, L., Gordon, M. A., Baines, P. A., Sinopoulou, V., & Akobeng, A. K. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007443.pub3 · Cited by 193 · see citing works

Probiotics and the Management of Inflammatory Bowel Disease

Fedorak, R. N., & Madsen, K. L. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200405000-00018 · Cited by 174 · see citing works

Probiotic Effects on Inflammatory Bowel Disease1,

Sheil, B., Shanahan, F., & O’Mahony, L. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.819s · Cited by 167 · see citing works

Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease

Seksik, P., Sokol, H., Lepage, P., Vasquez, N., Manichanh, C., Mangin, I., Pochart, P., Dore, J. M., & Marteau, P. R. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03053.x · Cited by 166 · see citing works

VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis

Dai, C., Zheng, C., Meng, F., Zhou, Z., Sang, L.-X., & Jiang, M. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1488-3 · Cited by 156 · see citing works

A comparative study of the preventative effects exerted by two probiotics,Lactobacillus reuteriandLactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis

Perán, L., Sierra, S., Comalada, M., Lara‐Villoslada, F., Bailón, E., Nieto, A., Concha, Á., Olivares, M. M., Zarzuelo, A., Xaus, J., et al. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507257770 · Cited by 155 · see citing works

Crohn's disease

Fellermann, K., Wehkamp, J., Herrlinger, K. R., & Stange, E. F. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200306000-00008 · Cited by 148 · see citing works

Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis

Ng, S. C., Plamondon, S., Kamm, M. A., Hart, A. L., Al-Hassi, H. O., Guenther, T., Stagg, A. J., & Knight, S. C. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21222 · Cited by 147 · see citing works

A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis

Wildt, S., Nordgaard, I., Hansen, U., Brockmann, E., & Rumessen, J. J. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2010.11.004 · Cited by 141 · see citing works

Probiotics in inflammatory bowel disease: possible mechanisms of action.

Dotan, I., & Rachmilewitz, D. (2005) · PubMed · Cited by 121 · see citing works

Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses

Kawashima, T., Hayashi, K., Kosaka, A., Kawashima, M., Igarashi, T., Tsutsui, H., Tsuji, N. M., Nishimura, I., Hayashi, T., & Obata, A. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.08.013 · Cited by 119 · see citing works

Mucosal Immunology and Probiotics

Dongarrà, M. L., Rizzello, V., Muccio, L., Fries, W., Cascio, A., Bonaccorsi, I., & Ferlazzo, G. (2012) · Current Allergy and Asthma Reports · doi:10.1007/s11882-012-0313-0 · Cited by 116 · see citing works

VSL#3 probiotics regulate the intestinal epithelial barrier in�vivo and in vitro via the p38 and ERK signaling pathways

Jiang, M. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.839 · Cited by 116 · see citing works

Antibiotics and probiotics in treatment of inflammatory bowel disease

Gionchetti, P. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i21.3306 · Cited by 113 · see citing works

Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate

Kumar, N. S. N., Ramadass, B., Jayakanthan, K., Pulimood, A. B., Pugazhendhi, S., & Ramakrishna, B. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05723.x · Cited by 102 · see citing works

Regulation of intestinal homeostasis by innate and adaptive immunity

Kayama, H., & Takeda, K. (2012) · International Immunology · doi:10.1093/intimm/dxs094 · Cited by 101 · see citing works

Physiological Basis for Novel Drug Therapies Used to Treat the Inflammatory Bowel Diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease

Shanahan, F. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00421.2004 · Cited by 82 · see citing works

Bacteria in the pathogenesis of inflammatory bowel disease

Subramanian, S., Campbell, B. J., & Rhodes, J. M. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000244054.69253.f3 · Cited by 75 · see citing works

Stories of love and hate

Rosenstiel, P. C. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835da2c7 · Cited by 49 · see citing works

Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: In vitro and in vivo considerations

Drouault-Holowacz, S., Foligné, B., Dennin, V., Goudercourt, D., Terpend, K., Burckel, A., & Pot, B. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.03.006 · Cited by 30 · see citing works

Re.: Oral administration of a certain strain of liveEscherichia coli for intestinal disorders? (Infection 23 [1995] 51–54)

Schulze, J., & Sonnenborn, U. (1995) · Infection · doi:10.1007/bf01793863 · Cited by 24 · see citing works

Maintaining Remission of Ulcerative Colitis with the Probiotic Escherichia Coli Nissle 1917 is as Effective as with Standard Mesalazine

Adam, B., Liebregts, T., & Holtmann, G. (2006) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2005-858972 · Cited by 24 · see citing works

Probiotic Bacteria in the Prevention and the Treatment of Inflammatory Bowel Disease

Fedorak, R. N., & Demeria, D. D. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.08.003 · Cited by 24 · see citing works

Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria

Hvas, C. L., Kelsen, J., Agnholt, J. S., Höllsberg, P., Tvede, M., Møller, J. K., & Dahlerup, J. F. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520601013754 · Cited by 22 · see citing works

Therapy with E.coli nissle reduces concentrations of mucosa associated colonic flora in patients with ulcerative colitis

Swidsinski, A. V., Swidsinski, S., Godzun, A., Orthner, M., & Lochs, H. H. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)80362-5 · Cited by 5 · see citing works

Escherichia coli strain nissie 1917 inhibits adhesion to an invasion of intestinal epithelial cells by adherent-invasive E. colil isolated from a Crohn's disease patient

Boudeau, J., Rich, C., Colombel, J., & DARTEUILLEMICHAUD, A. (2001) · Gastroenterology · doi:10.1016/s0016-5085(08)80940-7 · Cited by 2 · see citing works

[Probiotics--should we change the treatment strategy for pouchitis?].

Klinge, L. G., & Kjeldsen, J. (2006) · PubMed · Cited by 2 · see citing works

Influence of diet on the gut microbiome and implications for human health

Singh, R. K., Chang, H.-W., Yan, D., Lee, K. M., Ucmak, D., Wong, K., Abrouk, M., Farahnik, B., Nakamura, M., Zhu, T. H., et al. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1175-y · Cited by 2,599 · see citing works

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346 · see citing works

The gut microbiota and host health: a new clinical frontier

Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302 · see citing works

Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management

Harbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx009 · Cited by 1,180 · see citing works

Gut Microbiome: Profound Implications for Diet and Disease

Hills, R. D., Pontefract, B., Mishcon, H. R., Black, C. A., Sutton, S. C., & Theberge, C. R. (2019) · Nutrients · doi:10.3390/nu11071613 · Cited by 1,107 · see citing works

Environmental triggers in IBD: a review of progress and evidence

Ananthakrishnan, A. N., Bernstein, C. N., Iliopoulos, D., Macpherson, A., Neurath, M. F., Ali, R. A. R., Vavricka, S. R., & Fiocchi, C. (2018) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/nrgastro.2017.136 · Cited by 948 · see citing works

Evidence-based clinical practice guidelines for inflammatory bowel disease

Matsuoka, K., Kobayashi, T., Ueno, F., Matsui, T., Hirai, F., Inoue, N., Kato, J., Kobayashi, K., Kobayashi, K., Koganei, K., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1439-1 · Cited by 698 · see citing works

Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation

Shen, Z.-H., Zhu, C.-X., Quan, Y.-S., Yang, Z.-Y., Wu, S., Luo, W.-W., Tan, B., & Wang, X.-Y. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i1.5 · Cited by 646 · see citing works

The Gut Microbiota in Immune-Mediated Inflammatory Diseases

Forbes, J. D., Domselaar, G. V., & Bernstein, C. N. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01081 · Cited by 430 · see citing works

Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus

Bressler, B. L., Marshall, J. K., Bernstein, C. N., Bitton, A., Jones, J., Leontiadis, G. I., Panaccione, R., Steinhart, A. H., Tse, F., Feagan, B. G., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.001 · Cited by 414 · see citing works

Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease

Derwa, Y., Gracie, D. J., Hamlin, P. J., & Ford, A. C. (2017) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/apt.14203 · Cited by 393 · see citing works

Berberine pharmacology and the gut microbiota: A hidden therapeutic link

Habtemariam, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104722 · Cited by 352 · see citing works

Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease

Zhang, M., Sun, K., Wu, Y., Yang, Y., Tso, P., & Wu, Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00942 · Cited by 347 · see citing works

Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review

Ganji‐Arjenaki, M., & Rafieian‐Kopaei, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25911 · Cited by 314 · see citing works

Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease

Dupont, A. W., Richards, Jelinek, K. A., Krill, J. T., Rahimi, E. F., & Ghouri, Y. A. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s27530 · Cited by 303 · see citing works

Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies

Kim, D. H., & Cheon, J. H. (2017) · Immune Network · doi:10.4110/in.2017.17.1.25 · Cited by 288 · see citing works

Probiotics importance and their immunomodulatory properties

Yousefi, B., Eslami, M., Ghasemian, A., Kokhaei, P., Farrokhi, A. S., & Darabi, N. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27559 · Cited by 278 · see citing works

Diet and nutritional factors in inflammatory bowel diseases

Owczarek, D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.895 · Cited by 263 · see citing works

Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon

Cui, H., Cai, Y., Wang, L., Jia, B., Li, J., Zhao, S., Chu, X., Lin, J., Zhang, X., Bian, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00571 · Cited by 241 · see citing works

Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events : a systematic review

McFarland, L. V. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005047 · Cited by 235 · see citing works

<i>Bifidobacterium</i> can mitigate intestinal immunopathology in the context of CTLA-4 blockade

Wang, F., Yin, Q., Chen, L., & Davis, M. M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712901115 · Cited by 223 · see citing works

World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease

Bernstein, C. N., Eliakim, A. R., Fedail, S. S., Fried, M., Gearry, R. B., Goh, K., Hamid, S. S., Khan, A. G., Халиф, И. Л., Ng, S. C., et al. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000660 · Cited by 230 · see citing works

Colonic macrophage polarization in homeostasis, inflammation, and cancer

Isidro, R. A., & Appleyard, C. B. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00123.2016 · Cited by 229 · see citing works

Modulation of Fecal Clostridiales Bacteria and Butyrate by Probiotic Intervention with Lactobacillus paracasei DG Varies among Healthy Adults

Ferrario, C., Taverniti, V., Milani, C., Fiore, W., Laureati, M., De Noni, I., Stuknyte, M., Chouaia, B., Riso, P., & Guglielmetti, S. (2014) · The Journal of Nutrition · doi:10.3945/jn.114.197723 · Cited by 228 · see citing works

The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease

Parekh, P. J., Balart, L. A., & Johnson, D. A. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.16 · Cited by 219 · see citing works

Probiotics in Inflammatory Bowel Disease

Abraham, B. P., & Quigley, E. M. M. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.08.003 · Cited by 217 · see citing works

Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review

Jeong, D. Y., Kim, S., Son, M. J., Son, C. Y., Kim, J. Y., Kronbichler, A., Lee, K. H., & Shin, J. I. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.03.002 · Cited by 215 · see citing works

Probiotics for induction of remission in Crohn's disease

Limketkai, B. N., Akobeng, A. K., Gordon, M. A., & Adepoju, A. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006634.pub3 · Cited by 205 · see citing works

Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges

Martinez, R. C. R., Bedani, R., & Saad, S. M. I. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515003864 · Cited by 208 · see citing works

Probiotics in Autoimmune and Inflammatory Disorders

Liu, Y., Alookaran, J. J., & Rhoads, J. M. (2018) · Nutrients · doi:10.3390/nu10101537 · Cited by 199 · see citing works

Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A randomized controlled trial

Yılmaz, İ., Dolar, M. E., & Özpınar, H. (2019) · Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.18227 · Cited by 193 · see citing works

Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: A systematic review and meta-analysis

Zhang, X.-F., Guan, X.-X., Tang, Y.-J., Sun, J.-F., Wang, X.-K., Wang, W.-D., & Fan, J.-M. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02503-5 · Cited by 193 · see citing works

Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease

Wasilewski, A., Zielińska, M., Storr, M., & Fichna, J. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000364 · Cited by 186 · see citing works

Effect of Cigarette Smoke on Gut Microbiota: State of Knowledge

Gui, X., Yang, Z., & Li, M. D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.673341 · Cited by 188 · see citing works

Bifidobacteria—Insight into clinical outcomes and mechanisms of its probiotic action

Sarkar, A., & Mandal, S. (2016) · Microbiological Research · doi:10.1016/j.micres.2016.07.001 · Cited by 183 · see citing works

The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy

Cammarota, G., Ianiro, G., Cianci, R., Bibbò, S., Gasbarrini, A., & Currò, D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.006 · Cited by 180 · see citing works

Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis

Chamberlain, R., & Lau, C. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s98280 · Cited by 177 · see citing works

Review article: the gut microbiome in inflammatory bowel disease—avenues for microbial management

Mcilroy, J. R., Ianiro, G., Mukhopadhya, I., Hansen, R., & Hold, G. L. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14384 · Cited by 175 · see citing works

Role of gut microbiota via the gut-liver-brain axis in digestive diseases

Ding, J., Jin, Z., Yang, X., Lou, J., Shan, W., Hu, Y., Du, Q., Liao, Q., Xie, R., & Xu, J. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i40.6141 · Cited by 172 · see citing works

Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders

Currò, D., Ianiro, G., Pecere, S., Bibbò, S., & Cammarota, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13632 · Cited by 160 · see citing works

Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases

Cheifetz, A. S., Gianotti, R. J., Luber, R. P., & Gibson, P. R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.10.004 · Cited by 160 · see citing works

Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy forHelicobacter pylorieradication and prevention of adverse events

McFarland, L. V., Huang, Y., Wang, L., & Malfertheiner, P. (2015) · United European Gastroenterology Journal · doi:10.1177/2050640615617358 · Cited by 156 · see citing works

Polymeric carriers for enhanced delivery of probiotics

Asgari, S., Pourjavadi, A., Licht, T. R., Boisen, A., & Ajalloueian, F. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.014 · Cited by 155 · see citing works

The gut microbiota and inflammatory bowel diseases

Miyoshi, J., & Chang, E. B. (2016) · Translational research · doi:10.1016/j.trsl.2016.06.002 · Cited by 141 · see citing works

Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease

Gong, D., Gong, X., Wang, L., Yu, X., & Dong, Q. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/6951091 · Cited by 142 · see citing works

Probiotic Mix VSL#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis

Mardini, H. E., & Grigorian, A. Y. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000084 · Cited by 140 · see citing works

VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice

Wang, C.-S.-E., Li, W., Wang, H., Ma, Y., Zhao, X., Yang, H., Qian, J., & Li, J. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i37.4254 · Cited by 139 · see citing works

Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases

van den Elsen, L. W. J., Poyntz, H., Weyrich, L. S., Young, W., & Forbes‐Blom, E. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2016.91 · Cited by 127 · see citing works

Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases

Dolan, K. T., & Chang, E. B. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600129 · Cited by 129 · see citing works

Systematic review with meta‐analysis: the management of chronic refractory pouchitis with an evidence‐based treatment algorithm

Segal, J. P., Ding, N. S., Worley, G., McLaughlin, S. D., Preston, S., Faiz, O. D., Clark, S. K., & Hart, A. L. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13905 · Cited by 125 · see citing works

Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate

Gallo, A., Passaro, G., Gasbarrini, A., Landolfi, R., & Montalto, M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i32.7186 · Cited by 118 · see citing works

Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke

Zhao, L., Xiong, Q., Stary, C. M., Mahgoub, O. K., Ye, Y., Gu, L., Xiong, X., & Zhu, S. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1382-3 · Cited by 113 · see citing works

The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis

Astó, E., Méndez, I., Audivert, S., Farrán-Codina, A., & Espadaler, J. (2019) · Nutrients · doi:10.3390/nu11020293 · Cited by 109 · see citing works

Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches

Hansen, J. J., & Sartor, R. B. (2015) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0042-7 · Cited by 104 · see citing works

Nutrition and Supplementation in Ulcerative Colitis

Radziszewska, M., Smarkusz-Zarzecka, J., Ostrowska, L., & Pogodziński, D. (2022) · Nutrients · doi:10.3390/nu14122469 · Cited by 100 · see citing works

Perioperative dietary therapy in inflammatory bowel disease.

Adamina, M., Gerasimidis, K., Sigall-Boneh, R., Zmora, O., van Overstraeten, A. D. B., Campmans-Kuijpers, M., Ellul, P., Katsanos, K., Kotze, P., Noor, N., et al. (2019) · Journal of Crohn's & Colitis · doi:10.1093/ecco-jcc/jjz160 · Cited by 86 · see citing works

Probiotic administration can prevent necrotizing enterocolitis in preterm infants: A meta-analysis

Lau, C. S. M., & Chamberlain, R. S. (2015) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2015.05.008 · Cited by 98 · see citing works

Antioxidant Therapy in Inflammatory Bowel Diseases

Dziąbowska-Grabias, K., Sztanke, M., Zając, P., Celejewski, M., Kurek, K., Szkutnicki, S., Korga, P., Bulikowski, W., & Sztanke, K. (2021) · Antioxidants · doi:10.3390/antiox10030412 · Cited by 91 · see citing works

Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis

Ke, H., Li, F., Deng, W., Li, Z., Wang, S., Lv, P., & Chen, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.726707 · Cited by 91 · see citing works

An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease

Haskey, N., & Gibson, D. L. (2017) · Nutrients · doi:10.3390/nu9030259 · Cited by 89 · see citing works

Crosstalk between gut microbiota and host immune system and its response to traumatic injury

Ullah, H., Arbab, S., Tian, Y., Chen, Y., Liu, C., Li, Q., & Li, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1413485 · Cited by 93 · see citing works

Synbiotics for Improved Human Health: Recent Developments, Challenges, and Opportunities

Krumbeck, J. A., Walter, J., & Hutkins, R. W. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030117-012757 · Cited by 84 · see citing works

Baitouweng Tang ameliorates DSS-induced ulcerative colitis through the regulation of the gut microbiota and bile acids via pathways involving FXR and TGR5

Hua, Y., Jia, Y., Zhang, X., Yuan, Z., Ji, P., Hu, J., & Wei, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111320 · Cited by 81 · see citing works

Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease

Pandey, H., Jain, D., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Intestinal Research · doi:10.5217/ir.2023.00080 · Cited by 89 · see citing works

Adaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evalution of Diseases

Szilagyi, A. (2015) · Nutrients · doi:10.3390/nu7085309 · Cited by 83 · see citing works

Second Korean guidelines for the management of ulcerative colitis

Choi, C. H., Moon, W., Kim, Y. S., Kim, E. S., Lee, B., Jung, Y., Yoon, Y. S., Lee, H., Park, D. I., & Han, D. S. (2017) · Intestinal Research · doi:10.5217/ir.2017.15.1.7 · Cited by 79 · see citing works

Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy

Serban, D. E. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615606898 · Cited by 77 · see citing works

Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More

Schreiner, P., Neurath, M. F., Ng, S. C., El-Omar, E. M., Sharara, A. I., Kobayashi, T., Hisamatsu, T., Hibi∥, T., & Rogler, G. (2019) · Inflammatory Intestinal Diseases · doi:10.1159/000500721 · Cited by 75 · see citing works

Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta-analysis of randomized controlled trials.

Estevinho, M. M., Yuan, Y., Rodríguez‐Lago, I., Sousa‐Pimenta, M., Dias, C. C., Barreiro‐de Acosta, M., Jairath, V., & Magro, F. (2024) · United European gastroenterology journal · doi:10.1002/ueg2.12636 · Cited by 74 · see citing works

Attenuation of Colitis by Lactobacillus casei BL23 Is Dependent on the Dairy Delivery Matrix

Lee, B., Yin, X., Griffey, S. M., & Marco, M. L. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.01360-15 · Cited by 74 · see citing works

Nutritional Interventions in the Patient with Inflammatory Bowel Disease

Limketkai, B. N., Wolf, A., & Parian, A. M. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.09.007 · Cited by 74 · see citing works

Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients

Matijašić, M., Meštrović, T., Perić, M., Paljetak, H. Č., Panek, M., Bender, D. V., Kelečić, D. L., Krznarić, Ž., & Verbanac, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040578 · Cited by 71 · see citing works

The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood

Slattery, J. M., MacFabe, D. F., & Frye, R. E. (2016) · Clinical Medicine Insights Pediatrics · doi:10.4137/cmped.s38338 · Cited by 72 · see citing works

Drug delivery to the inflamed intestinal mucosa – targeting technologies and human cell culture models for better therapies of IBD

Hartwig, O., Boushehri, M. A. S., Shalaby, K. S., Loretz, B., Lamprecht, A., & Lehr, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113828 · Cited by 72 · see citing works

Efficacy of the Punica granatum peels aqueous extract for symptom management in ulcerative colitis patients. A randomized, placebo-controlled, clinical trial

Kamali, M., Tavakoli, H., Khodadoost, M., Daghaghzadeh, H., Kamalinejad, M., Gachkar, L., Mansourian, M., & Adibi, P. (2015) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2015.03.001 · Cited by 71 · see citing works

Dietary Non-digestible Polysaccharides Ameliorate Intestinal Epithelial Barrier Dysfunction in IL-10 Knockout Mice

Wang, H.-G., Shi, P., Zuo, L., Dong, J., Zhao, J., Liu, Q., & Zhu, W. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw065 · Cited by 70 · see citing works

Inhibition of Chronic Ulcerative Colitis-associated Adenocarcinoma Development in Mice by VSL#3

Talero, E., Bolívar, S., Ávila‐Román, J., Alcaide, A. M., Fiorucci, S., & Motilva, V. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000346 · Cited by 69 · see citing works

The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease.

Lin, S. C., & Cheifetz, A. S. (2018) · Europe PMC (PubMed Central) · Cited by 66 · see citing works

The Microbiome and Sustainable Healthcare

Dietert, R. R., & Dietert, J. M. (2015) · Healthcare · doi:10.3390/healthcare3010100 · Cited by 67 · see citing works

Intestinal microbiome as a novel therapeutic target for local and systemic inflammation

Uchiyama, K., Naito, Y., & Takagi, T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.006 · Cited by 65 · see citing works

Effects of Fermented Food Consumption on Non-Communicable Diseases

Patel, P. V., Butani, K., Kumar, A., Singh, S. K., & Prajapati, B. G. (2023) · Foods · doi:10.3390/foods12040687 · Cited by 64 · see citing works

Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial

Harnett, J., Myers, S. P., & Rolfe, M. I. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/9048574 · Cited by 67 · see citing works

The role of dietary supplements in inflammatory bowel disease: a systematic review

Rossi, R. E., Whyand, T., Murray, C. D., Hamilton, M., Conte, D., & Caplin, M. E. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000728 · Cited by 63 · see citing works

Lactobacillus plantarum Enhanced IL-22 Production in Natural Killer (NK) Cells That Protect the Integrity of Intestinal Epithelial Cell Barrier Damaged by Enterotoxigenic Escherichia coli

Qiu, Y., Jiang, Z., Hu, S., Wang, L., Ma, X., & Yang, X. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112409 · Cited by 63 · see citing works

Recommendations for Probiotic Use in Humans—A 2014 Update

Floch, M. H. (2014) · Pharmaceuticals · doi:10.3390/ph7100999 · Cited by 62 · see citing works

IBD and the Gut Microbiota—from Bench to Personalized Medicine

Bellaguarda, E., & Chang, E. B. (2015) · Current Gastroenterology Reports · doi:10.1007/s11894-015-0439-z · Cited by 62 · see citing works

Protective effect of exopolysaccharide fraction from Bacillus subtilis against dextran sulfate sodium-induced colitis through maintenance of intestinal barrier and suppression of inflammatory responses

Chung, K., Shin, J., Lee, J.-H., Park, S.-E., Han, H.-S., Rhee, Y. K., Cho, C., Hong, H., & Lee, K. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.186 · Cited by 62 · see citing works

The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment

Ekmekçiu, I., von Klitzing, E., Fiebiger, U., Neumann, C., Bächer, P., Scheffold, A., Bereswill, S., & Heimesaat, M. M. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00167 · Cited by 61 · see citing works

Influence of Diet on the Course of Inflammatory Bowel Disease

Tasson, L., Canova, C., Vettorato, M. G., Savarino, E. V., & Zanotti, R. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4620-0 · Cited by 62 · see citing works

Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity

Biagioli, M., Laghi, L., Carino, A., Cipriani, S., Distrutti, E., Marchianò, S., Parolin, C., Scarpelli, P. T., Vitali, B., & Fiorucci, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00505 · Cited by 60 · see citing works

Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease

Quraishi, M. N., Shaheen, W., Oo, Y. H., & Iqbal, T. H. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13397 · Cited by 62 · see citing works

A pilot study on the effects of probiotic supplementation on neuropsychological performance and micro RNA ‐29a‐c levels in antiretroviral‐treated HIV ‐1‐infected patients

Ceccarelli, G., Fratino, M., Selvaggi, C., Giustini, N., Serafino, S., Schietroma, I., Scheri, G. C., Pavone, P., Passavanti, G., Fegatelli, D. A., et al. (2017) · Brain and Behavior · doi:10.1002/brb3.756 · Cited by 60 · see citing works

Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022

Huang, C., Hao, W., Wang, X., Zhou, R., & Lin, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1211271 · Cited by 61 · see citing works

Review of the role of probiotics in gastrointestinal diseases in adults

Domingo, J. J. S. (2017) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2016.12.001 · Cited by 60 · see citing works

The Role of Prebiotics and Probiotics in Gastrointestinal Disease

Floch, M. H. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.09.011 · Cited by 57 · see citing works

Probiotics in early life: a preventative and treatment approach

Hashemi, A., Villa, C., & Comelli, E. M. (2016) · Food & Function · doi:10.1039/c5fo01148e · Cited by 56 · see citing works

Gastrointestinal symptoms, gut microbiome, probiotics and prebiotics in anorexia nervosa: A review of mechanistic rationale and clinical evidence

Dhopatkar, N., Keeler, J. L., Mutwalli, H., Whelan, K., Treasure, J. L., & Himmerich, H. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105959 · Cited by 57 · see citing works

Gut microbiota in regulatory T cell generation and function: mechanisms and health implications

Sharma, A., Sharma, G., & Im, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2516702 · Cited by 65 · see citing works

A novel non-dairy beverage from durian pulp fermented with selected probiotics and yeast

Lu, Y., Putra, S. D., & Liu, S. (2017) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2017.10.030 · Cited by 54 · see citing works

Berberine in the treatment of ulcerative colitis: A possible pathway through Tuft cells

Xiong, X., Cheng, Z., Wu, F., Hu, M., Liu, Z., Dong, R., & Chen, G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111129 · Cited by 55 · see citing works

Effect of probiotics on remission,relapse and pouchitis in inflammatory bowel disease:meta-analysis

Xiao, S. (2008) · Chinese Journal of Gastroenterology and Hepatology · Cited by 1 · see citing works

Effect of probiotic preparations on inducing and mainfaining remission of ulcerative colitis:a meta-analysis

Yan-fan, Y. (2010) · Jiefangjun yixue zazhi · Cited by 1 · see citing works

Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis

Sang, L.-X. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i15.1908 · Cited by 133 · see citing works

Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease

Derwa, Y., Gracie, D. J., Hamlin, P. J., & Ford, A. C. (2017) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/apt.14203 · Cited by 393 · see citing works

P622 Efficacy of probiotics in inflammatory bowel disease: systematic review and meta-analysis

Derwa, Y. H., Gracie, D. J., Hamlin, P. J., & Ford, A. C. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx002.746 · Cited by 7 · see citing works